Mega Nirman Industries Ltd vs Prism Medico Pharmacy Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Mega Nirman & Industries Ltd is ₹ 53.2 as of 23 Oct 15:30 . The P/E Ratio of Mega Nirman & Industries Ltd changed from 55.7 on March 2021 to 285.1 on March 2026 . This represents a CAGR of 31.28% over 6 yearsThe P/E Ratio of Prism Medico & Pharmacy Ltd changed from 47.6 on March 2026 to 47.6 on March 2026 . This represents a CAGR of 0.00% over 1 years The Market Cap of Mega Nirman & Industries Ltd changed from ₹ 2.61 crore on March 2021 to ₹ 102.36 crore on March 2026 . This represents a CAGR of 84.32% over 6 yearsThe Market Cap of Prism Medico & Pharmacy Ltd changed from ₹ 7.06 crore on March 2021 to ₹ 15.29 crore on March 2026 . This represents a CAGR of 13.75% over 6 years The revenue of Mega Nirman & Industries Ltd for the Jun '26 is ₹ 2.82 crore as compare to the Mar '26 revenue of ₹ 3.47 crore. This represent the decline of -18.73% The revenue of Prism Medico & Pharmacy Ltd for the Jun '26 is ₹ 0.09 crore as compare to the Mar '26 revenue of ₹ 0.28 crore. This represent the decline of -67.86% The ebitda of Mega Nirman & Industries Ltd for the Jun '26 is ₹ 0.1 crore as compare to the Mar '26 ebitda of ₹ 0.71 crore. This represent the decline of -85.92% The ebitda of Prism Medico & Pharmacy Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.12 crore. This represent the decline of -50% The net profit of Mega Nirman & Industries Ltd changed from ₹ -0.1 crore to ₹ 0.03 crore over 9 quarters. This represents a CAGR of NaN% The net profit of Prism Medico & Pharmacy Ltd changed from ₹ -0.09 crore to ₹ -0.06 crore over 9 quarters. This represents a CAGR of -16.49% The Dividend Payout of Mega Nirman & Industries Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Prism Medico & Pharmacy Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Mega Nirman & Industries Ltd

Mega Nirman & Industries Limited was originally incorporated on March 23, 1983 with the name 'Daphene Investment and Properties Limited', as a Public Limited Company.
The Company changed its name from 'Daphene Investment and Properties Limited' to 'Mega Nirman & Industries Limited' and a fresh Certificate of Incorporation was issued by the Registrar of Companies. The Company is involved in the business of acquiring, dealing in other precious metals, precious stones, jewellery and buying, selling and dealing, wholesale and retailing, in precious metals, precious stones, jewellery and articles made of precious metals, precious stones articles of virtue and objects of art. Company has developed some of the modern and finest residential and commercial complexes in Rajasthan and Delhi Noida, National Capital Region (NCR) and new urban settlement like Meerut, Moradabad, Haridwar and Rudrapur.

About Prism Medico & Pharmacy Ltd

Prism Medico and Pharmacy Limited was originally incorporated under the name of Woolite Mercantile Company Limited on 21st February, 1985.
The name of the Company was changed from Woolite Mercantile Company Limited to Prism Medico and Pharmacy Limited dated January 9, 2012.
Initially, the Company was engaged into Wholesale and Retail of straw, fodder and other animal/poultry feed.
It also engaged into investments, share trading, and financial activities. Over the past years, the Company was not able to carry out any major operations, resulting it engaged in trading. During FY 2022-23, the main objects of the Memorandum of Association of the Company were altered so as to manufacture, formulate, process, develop, refine, import, export, wholesale and/or retail trade all kinds of pharmaceuticals, antibiotics, drugs, medicines, biological, neutraceuticals, healthcare, ayurvedic and dietary supplement products, medicinal preparations, vaccines, chemicals, chemical products, dry salters, mineral waters, wines, cordials, liquors, soups, broths and other restoratives or foods and also to deal in medicinal goods.

FAQs for the comparison of Mega Nirman & Industries Ltd and Prism Medico & Pharmacy Ltd

Which company has a larger market capitalization, Mega Nirman & Industries Ltd or Prism Medico & Pharmacy Ltd?

Market cap of Mega Nirman & Industries Ltd is 136 Cr while Market cap of Prism Medico & Pharmacy Ltd is 42 Cr

What are the key factors driving the stock performance of Mega Nirman & Industries Ltd and Prism Medico & Pharmacy Ltd?

The stock performance of Mega Nirman & Industries Ltd and Prism Medico & Pharmacy Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mega Nirman & Industries Ltd and Prism Medico & Pharmacy Ltd?

As of October 25, 2026, the Mega Nirman & Industries Ltd stock price is INR ₹53.2. On the other hand, Prism Medico & Pharmacy Ltd stock price is INR ₹31.52.

How do dividend payouts of Mega Nirman & Industries Ltd and Prism Medico & Pharmacy Ltd compare?

To compare the dividend payouts of Mega Nirman & Industries Ltd and Prism Medico & Pharmacy Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.